Immunocore Holdings (IMCR) Stock Statistics & Valuation Metrics

Immunocore Holdings has a market cap or net worth of $1.82B. The enterprise value is $1.33B.

Immunocore Holdings has 50,233,610 shares outstanding. The number of shares has decreased by -2.65% in one year.

Immunocore Holdings’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -8.50%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Immunocore Holdings had revenue of 310.20M and earned -51.09M in profits. Earnings per share was -1.02.

In the last 12 months, operating cash flow was 31.08M and capital expenditures -5.04M, giving a free cash flow of 26.04M billion.

Immunocore Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Immunocore Holdings upcoming earnings date is Aug 6, 2025, Before Open (Confirmed).

Immunocore Holdings as a current ratio of 4.38, with Debt / Equity ratio of 11.22%

In the past 12 months, Immunocore Holdings has paid -1.85M in taxes.

Immunocore Holdings EV to EBITDA ratio is -20.60, with an EV/FCF ratio of 69.50.

Immunocore Holdings has $837.03M in cash and marketable securities with £42.47M in debt, giving a net cash position of -$794.57M billion.

Gross margin is 99.01%, with operating margin of -22.71%, and net profit margin of -16.47%.

The average price target for Immunocore Holdings is $66.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy